2 Healthcare Stocks That Could Soar in 2020

The end of the year is fast approaching. And for investors, several things are worth keeping an eye on between now and December. The presidential race is one example. The results of the November elections in the U.S. could affect the market -- positively or otherwise. Another race to pay attention to is the coronavirus vaccine race. For companies working on this project, notable progress toward an effective vaccine could generate substantial stock market gains.

That's why Vaxart (NASDAQ: VXRT) and Novavax (NASDAQ: NVAX) are worth monitoring. These biotechs have already rewarded many investors this year, but there's still a long runway for growth. Depending on how their COVID-19 efforts evolve, Vaxart and Novavax could soar even more before the curtain closes on 2020. Let's take a closer look at these companies and figure out whether they are worth investing in today.